(Q51175881)

English

Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.

scientific article published in July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

Cytomegalovirus

0 references

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

Claudia Lengerke

1

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

author name string

Ljubicic T

2

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

Meisner C

3

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

Loeffler J

4

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

Sinzger C

5

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

Einsele H

6

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

Hebart H

7

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

language of work or name

0 references

publication date

1 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

38

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

1

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

53-60

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Strategies for the prevention of cytomegalovirus disease after marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Comparison of DNA amplification, mRNA amplification, and DNA hybridization techniques for detection of cytomegalovirus in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Interrelationships among Quantity of Human Cytomegalovirus (HCMV) DNA in Blood, Donor‐Recipient Serostatus, and Administration of Methylprednisolone as Risk Factors for HCMV Disease following Liver Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

21 January 2018

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Early effects of ganciclovir therapy on the quantity of cytomegalovirus DNA in leukocytes of immunocompromised patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Foscarnet--an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705408

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705408

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16788683

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51175881&oldid=2210744783"